How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? – Edwards Lifesciences, Stryker, Accuray, and ABIOMED

NEW YORK, June 8, 2016 /PRNewswire/ —

Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. has lined the following stocks for investors’ assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:

Let us now take a look at these stocks at close range:

Irvine, California headquartered Edwards Lifesciences Corp.’s stock finished Tuesday’s trading session 0.05% higher at $101.50. A total volume of 980,875 shares was traded. The Company’s shares have advanced 19.24% over the previous three months and 28.51% since the start of this year. The stock is trading above its 200-day moving average by 20.51%. Additionally, shares of Edwards Lifesciences, which offers products and technologies to treat structural heart disease and critically ill patients globally, have a Relative Strength Index (RSI) of 48.55. Do not lose out on any EW’s trade by activating your free access to the trade alerts now at:

On Tuesday, shares in Kalamazoo, Michigan-based medical technology Company, Stryker Corp., which operates through three segments – Orthopaedics; MedSurg; and Neurotechnology and Spine, ended the session at $112.59, which was a slight correction of 0.83%. The stock recorded a trading volume of 1.41 million shares, which was higher than its three months average volume of 1.37 million shares. The Company’s shares have gained 1.24% in the last one month, 9.94% in the previous three months, and 21.58% on an YTD basis. The stock is trading 2.39% above its 50-day moving average and 12.86% above its 200-day moving average. Moreover, shares of Stryker have an RSI of 58.39. Sign up for your trade alert on SYK at:

Sunnyvale, California headquartered designer, developer, and seller of radiosurgery and radiation therapy systems for the treatment of tumors in the body, Accuray Inc.’s shares gained 0.90%, closing the session at $5.61. The stock recorded a trading volume of 371,421 shares. The Company’s shares have gained 10.65% in the last one month and 3.31% over the previous three months. The stock is trading 0.62% above its 50-day moving average. Additionally, shares of Accuray have an RSI of 58.23. Register for free on and activate your trade alert on ARAY at:

At the close on Tuesday, Danvers, Massachusetts headquartered ABIOMED Inc.’s stock recorded a trading volume of 588,009 shares and ended the day 2.38% higher at $104.31. The Company’s shares have advanced 9.87% in the past month, 23.81% over the previous three months, and 15.54% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 6.81% and 16.50%, respectively. Furthermore, shares of ABIOMED have an RSI of 70.01.  Trade alert on ABMD is available for free at:


Active Wall Street: 

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

AWS has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Most Popular

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2015 A Daily News.

To Top